Severe type of Epstein-Barr virus associated hemophagocytic syndrome successfully treated with T-COP-E and splenectomy

Japanese Journal of Clinical Immunology

Volumn 26, Issue 2, 2003, Pages 80-86

  Shiozawa, Eisuke ^a   Kawakami, Keiichiro ^a   Matsuda, Isao ^a   Nakamaki, Tsuyoshi ^a   Hino, Ken Ichiro ^b   Ota, Hidekazu ^a   Tomoyasu, Shigeru ^a  

^a SHOWA UNIVERSITY   (Japan)

^b Tsurukawa Sanatorium Hospital   (Japan)

Author keywords

EBV associated hemophagocytic syndrome; Splenectomy; T COP E

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG DERIVATIVE; ETOPOSIDE; PIRARUBICIN; PREDNISOLONE; VINCRISTINE;

ADOLESCENT; ARTICLE; CASE REPORT; DRUG COMBINATION; FEMALE; HISTIOCYTOSIS; HUMAN; SPLENECTOMY; VIRUS INFECTION;

ADOLESCENT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG THERAPY, COMBINATION; EPSTEIN-BARR VIRUS INFECTIONS; ETOPOSIDE; FEMALE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; PREDNISOLONE; SPLENECTOMY; VINCRISTINE;

EID: 0038071741     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.26.80     Document Type: Article

References (13)

1. Imashuku, S., et al.: Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohis-tiocytosis. Med. Pediatr. Oncol. 31: 131–137, 1998.
2. Henter, J.I., et al.: Diagnostic guidelines for hemophagocytic lymphohistiocytosis, Semin. Oncol. 18: 29–33, 1991.
3. Saito, I., et al.: Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren’s syndrome. J. Exp. Med. 169: 2191–2198, 1989.
4. Saito, I., et al.: Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren’s syndrome. Epstein-Barr virus (EBV) 3885: 37–45, 1998.
5. S., Imashuku, Differential diagnosis of hemophagocytic syndrome: Underlying disorders and selection of most effective treatment, Int. J. Hematol., (1997), 66, 135-151
6. Tsuda, H.: Hemophagocytic syndrome (HPS) in children and adults. Int. J. Hematol. 65: 215–226, 1997.
7. Henter, J.-I., et al.: HLH- 94: A treatment protocol for hemophagocytic lymphohistiocytosis. Med. Pediatr. Oncol. 28: 342–347, 1997.
8. Imashuku, S., et al.: Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood 93: 1869–1874, 1999.
9. Tsuda, H., Shirono, K.: Successful treatment of virus-associated hemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony-stimulating factor. Br. J. Hematol. 93: 572–575, 1996.
10. Loughran, Jr., T.P., et al.: Evaluation of splenectomy in large granular lymphocyte leukemia. Br. J. Hematol. 67: 135–140, 1987.
11. S., Imashuku, et al., Splenectomy in haemo-phagocytic lymphohistiocytosis: Report of histopathological changes with CD19 + B-cell depletion and therapeutic results, Br. J. Hematol., (2000), 108, 505-510
12. Morishima, N., et al.: A case of uveitis associated with chronic active Epstein-Barr virus infection. Ophthalmol. 210: 186–188, 1996.
13. Imashuku, S., et al.: Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J. Clin. Oncol. 19: 2665–2673, 2001.